← Open Payments lookup

VIOLET AMIRJALALI: Open Payments

NPI 1558686659 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,238 in 176 payments from 38 companies in 2025. Trend: 2023 $3,535 · 2024 $3,846 · 2025 $3,238

Food & beverage: $3,230Education: $8
CompanyPaymentsAmount
Novo Nordisk Inc17$329
Amgen Inc.18$307
ABBVIE INC.14$207
Bayer Healthcare Pharmaceuticals Inc.12$187
Dexcom, Inc.8$170
Xeris Pharmaceuticals, Inc.9$167
RECORDATI_RARE_DISEASES_INC.16$141
Almatica Pharma LLC6$138
Tandem Diabetes Care, Inc.6$138
Ascendis Pharma Endocrinology Inc10$137

Products named: Ozempic, REPATHA, Kerendia, Dexcom G6 Transmitter, TERIPARATIDE, JARDIANCE, GVOKE HYPOPEN, ISTURISA.

Industry payments across NV — which companies pay providers there.